Refine by
Peripheral Arterial Disease Articles & Analysis
12 articles found
MMPs are involved in pathological processes such as hypertension, eclampsia, vascular inflammation, atherosclerosis, coronary syndromes and myocardial infarction, cerebral ischemia and ischemic stroke, peripheral arterial disease, aneurysms, chronic venous disease, etc. MMPs can be used as biomarkers and potential therapeutic ...
Start-up Alucent Biomedical is using a light-activated molecule, delivered via a balloon catheter, to create a natural vascular scaffold in diseased peripheral vessels, with the aim of providing a long-lasting treatment option that maintains patency while leaving nothing behind in the vessel. Alucent Biomedical Inc. is rethinking peripheral ...
Patient History Patient presented with a history of hypertension, hyperlipidemia, peripheral arterial disease, obesity, arterial fibrillation, and transient ischemic attack. ...
Before a patient can get fit with their multi-articulating myoelectric hand, it’s vital that their prosthetist conducts a thorough evaluation and understands the cause of amputation or limb loss. This information helps prosthetists understand what a patient’s needs are so they can determine which prosthetic hand is the best fit for them. With this in mind, we’ll discuss the ...
We report a first-in-man clinical experience using the HAV for arterial reconstruction in patients with symptomatic peripheral arterial disease. ...
Most of these amputations are performed for the treatment of non-healing diabetic foot ulcers that resulted from PAD (Peripheral Arterial Disease). These non-healing foot ulcers are caused by high blood glucose levels, which accelerate the direct damage to the nerves and blood vessels in the body, specifically the limbs. ...
Individuals with chronic wounds (diabetic foot ulcers, pressure ulcers, venous ulcers, arterial ulcers, etc.) commonly have other chronic conditions – typically type 2 diabetes, hypertension, venous insufficiency, peripheral arterial disease, and/or chronic kidney disease. ...
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has signed an agreement to acquire Vesper Medical Inc., a US-based medical technology company that develops minimally-invasive peripheral vascular devices. Vesper Medical will further expand Philips’ portfolio of diagnostic and ...
As the most advanced stage of peripheral arterial disease (PAD), chronic limb-threatening ischemia (CLTI) is associated with a high risk of lower-limb loss and mortality. ...
Traditionally, chronic limb-threatening ischemia (CLTI) is considered the final clinical manifestation of peripheral artery disease (PAD), presenting with rest pain or tissue loss.1 PAD is described as a plaque-based, atherosclerotic big artery disease (BAD) starting with focal or multifocal lipid deposits inside ...
Alucent’s first area of focus is one the most debilitating vascular diseases –peripheral artery disease, plaque build-up in mainly the legs that narrows blood flow causing excruciating pain. Their hope is to ultimately make the well-known ‘stent,’ currently used to maintain diseased ...
The increasing incidence of peripheral artery disease (PAD) is occurring globally as populations age and rates of diabetes, obesity, and renal disease increase.1-3 Although most of these patients have no symptoms, when the disease progresses to its most advanced form, chronic limb-threatening ischemia (CLTI), ...